ArticleOncogene2026

Dual-target CAR-T therapy for ovarian cancer: synergistic targeting of MSLN and B7H3 enhances anti-tumor efficacy and overcomes antigen heterogeneity.

Feng Ji et al.PubMed ↗Publisher ↗

No numbers read from the abstract.